Literature DB >> 22798739

Cognitive impairment in hepatitis C patients on antiviral therapy.

Jessica Irwin1, Norah Terrault.   

Abstract

Entities:  

Year:  2008        PMID： 22798739      PMCID： PMC3394472     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  38 in total

Review 1.  Cytokines and the brain: implications for clinical psychiatry.

Authors:  Z Kronfol; D G Remick
Journal:  Am J Psychiatry       Date:  2000-05       Impact factor: 18.112

2.  Neurocognitive changes in patients with hepatitis C receiving interferon alfa-2b and ribavirin.

Authors:  Michael R Kraus; Arne Schäfer; Saskia Wissmann; Peter Reimer; Michael Scheurlen
Journal:  Clin Pharmacol Ther       Date:  2005-01       Impact factor: 6.875

3.  A Persistent Dementia-like Condition Following Treatment of Hepatitis C With Pegylated Interferon and Ribavirin.

Authors:  Susan Ruffner-Statzer; Allan L Bernstein
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-01

4.  Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease.

Authors:  Daniel M Forton; Howard C Thomas; Christine A Murphy; Joanna M Allsop; Graham R Foster; Janice Main; Keith A Wesnes; Simon D Taylor-Robinson
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

5.  Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis.

Authors:  Herbert L Bonkovsky; Kristin K Snow; Peter F Malet; Carla Back-Madruga; Robert J Fontana; Richard K Sterling; Clark C Kulig; Adrian M Di Bisceglie; Timothy R Morgan; Jules L Dienstag; Marc G Ghany; David R Gretch
Journal:  J Hepatol       Date:  2006-11-27       Impact factor: 25.083

6.  Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction.

Authors:  Charles L Raison; Andrey S Borisov; Sherry D Broadwell; Lucile Capuron; Bobbi J Woolwine; Ira M Jacobson; Charles B Nemeroff; Andrew H Miller
Journal:  J Clin Psychiatry       Date:  2005-01       Impact factor: 4.384

7.  A randomized controlled trial of pegylated interferon alpha-2a (40 KD) or interferon alpha-2a plus ribavirin and amantadine vs interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C.

Authors:  A Mangia; G L Ricci; M Persico; N Minerva; V Carretta; D Bacca; M Cela; M Piattelli; M Annese; G Maio; D Conte; V Guadagnino; V Pazienza; D Festi; F Spirito; A Andriulli
Journal:  J Viral Hepat       Date:  2005-05       Impact factor: 3.728

Review 8.  NIH Consensus Statement on Management of Hepatitis C: 2002.

Authors: 
Journal:  NIH Consens State Sci Statements       Date:  2002 Jun 10-12

9.  Electroencephalographic abnormalities in interferon encephalopathy: a preliminary report.

Authors:  C C Suter; B F Westmoreland; F W Sharbrough; R C Hermann
Journal:  Mayo Clin Proc       Date:  1984-12       Impact factor: 7.616

10.  Cognitive function does not worsen during pegylated interferon and ribavirin retreatment of chronic hepatitis C.

Authors:  Robert J Fontana; Linas A Bieliauskas; Karen L Lindsay; Carla Back-Madruga; Elizabeth C Wright; Kristin K Snow; Anna S F Lok; Ziad Kronfol; Latha Padmanabhan
Journal:  Hepatology       Date:  2007-05       Impact factor: 17.425
View more
  1 in total

1.  Nonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials.

Authors:  Lien-Chieh Lin; Tzu-Herng Hsu; Kuang-Wei Huang; Ka-Wai Tam
Journal:  World J Gastroenterol       Date:  2016-06-21       Impact factor: 5.742
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.